HKD 1.16
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 2.92 Billion CNY | -1.3% |
2022 | 2.96 Billion CNY | 27.78% |
2021 | 2.31 Billion CNY | 20.73% |
2020 | 1.91 Billion CNY | 0.5% |
2019 | 1.9 Billion CNY | 12.89% |
2018 | 1.69 Billion CNY | -12.14% |
2017 | 1.92 Billion CNY | 18.79% |
2016 | 1.62 Billion CNY | 17.2% |
2015 | 1.38 Billion CNY | 12.33% |
2014 | 1.23 Billion CNY | 11.35% |
2013 | 1.1 Billion CNY | 15.08% |
2012 | 960.61 Million CNY | 11.93% |
2011 | 858.25 Million CNY | 16.09% |
2010 | 739.28 Million CNY | 15.86% |
2009 | 638.08 Million CNY | -0.41% |
2008 | 640.72 Million CNY | -16.62% |
2007 | 768.45 Million CNY | 52.91% |
2006 | 502.54 Million CNY | 60.47% |
2005 | 313.17 Million CNY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 2.99 Billion CNY | 0.0% |
2023 Q4 | 2.92 Billion CNY | 0.0% |
2023 FY | 2.92 Billion CNY | -1.3% |
2023 Q2 | 3.02 Billion CNY | 0.0% |
2022 FY | 2.96 Billion CNY | 27.78% |
2022 Q2 | 2.79 Billion CNY | 0.0% |
2022 Q4 | 2.96 Billion CNY | 0.0% |
2021 Q4 | 2.31 Billion CNY | 0.0% |
2021 FY | 2.31 Billion CNY | 20.73% |
2021 Q2 | 1.96 Billion CNY | 0.0% |
2020 Q4 | 1.91 Billion CNY | 0.0% |
2020 FY | 1.91 Billion CNY | 0.5% |
2020 Q2 | 1.89 Billion CNY | 0.0% |
2019 FY | 1.9 Billion CNY | 12.89% |
2019 Q2 | 1.65 Billion CNY | 0.0% |
2019 Q4 | 1.9 Billion CNY | 0.0% |
2018 Q2 | 1.8 Billion CNY | 0.0% |
2018 Q4 | 1.69 Billion CNY | 0.0% |
2018 FY | 1.69 Billion CNY | -12.14% |
2017 FY | 1.92 Billion CNY | 18.79% |
2017 Q4 | 1.92 Billion CNY | 0.0% |
2017 Q2 | 1.74 Billion CNY | 0.0% |
2016 Q2 | 1.47 Billion CNY | 0.0% |
2016 FY | 1.62 Billion CNY | 17.2% |
2016 Q4 | 1.62 Billion CNY | 0.0% |
2015 Q4 | 1.38 Billion CNY | 0.0% |
2015 Q2 | 1.33 Billion CNY | 0.0% |
2015 FY | 1.38 Billion CNY | 12.33% |
2014 FY | 1.23 Billion CNY | 11.35% |
2014 Q2 | 1.15 Billion CNY | 0.0% |
2014 Q4 | 1.23 Billion CNY | 0.0% |
2013 Q2 | 1.12 Billion CNY | 0.0% |
2013 FY | 1.1 Billion CNY | 15.08% |
2013 Q4 | 1.1 Billion CNY | 0.0% |
2012 Q2 | 897.47 Million CNY | 0.0% |
2012 Q4 | 960.61 Million CNY | 0.0% |
2012 FY | 960.61 Million CNY | 11.93% |
2011 Q2 | 798.25 Million CNY | 0.0% |
2011 FY | 858.25 Million CNY | 16.09% |
2011 Q4 | 858.25 Million CNY | 0.0% |
2010 Q2 | 637.67 Million CNY | 0.0% |
2010 FY | 739.28 Million CNY | 15.86% |
2010 Q4 | 739.28 Million CNY | 0.0% |
2009 FY | 638.08 Million CNY | -0.41% |
2009 Q4 | 638.08 Million CNY | 0.0% |
2009 Q2 | 652.54 Million CNY | 0.0% |
2008 Q4 | 640.72 Million CNY | 0.0% |
2008 FY | 640.72 Million CNY | -16.62% |
2007 FY | 768.45 Million CNY | 52.91% |
2006 FY | 502.54 Million CNY | 60.47% |
2005 FY | 313.17 Million CNY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 240.23 Million HKD | -1116.254% |
Lee & Man Chemical Company Limited | 7.02 Billion HKD | 58.432% |